Article Text

veterinary medicines
Veterinary medicines: product update

Statistics from

The following information has been produced for Veterinary Record by the Veterinary Medicines Directorate (VMD) to provide an update for veterinary surgeons on recent changes to marketing authorisations for veterinary medicines in the UK and other relevant issues.

THE points below highlight changes in marketing authorisations that may have a significant impact on veterinary surgeons' prescribing decisions.

New marketing authorisations

New marketing authorisations relevant to veterinary surgeons in the UK that were issued in December 2011 are listed in Table 1. Of the products listed, only Truscient 0.66 mg kit for implant for dogs contains an active ingredient – dibotermin alfa – not previously included in an authorised veterinary medicinal product in the UK.

View this table:
Table 1

Marketing authorisations issued in December 2011

These products may not yet be readily available in the UK. Veterinary surgeons should contact the marketing authorisation holder directly for details of supply.

Table 1 also indicates where a public assessment report should become available for a product on the VMD's website. Where available, links to these reports are accessible by clicking on the relevant product in the VMD's Product Information Database,

The European Medicines Agency (EMA) publishes European Public …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.